Selective RAR agonists for acne vulgaris: A narrative review.

Martin KassirPriyanka KaragaiahSidharth SonthaliaAndreas KatsambasHassan I GaladariMrinal GuptaTorello LottiUwe WollinaAyman AbdelmaksoudStephan GrabbeMohamad Goldust

Published in: Journal of cosmetic dermatology (2020)

Trifarotene is a new 4th generation retinoid with selective action on RAR-γ receptor alone, which is specific for skin, and it is safe for long-term maintenance therapy with good efficacy and tolerability.

Keyphrases

open label
randomized controlled trial
wound healing
stem cells
binding protein
hidradenitis suppurativa
double blind
bone marrow
mesenchymal stem cells